精神分裂症中CPEB4的致病性错误剪接
该研究基于精神分裂症遗传数据与死後脑组织,发现CPEB4微外显子剪接异常导致其靶向的精神分裂症风险基因蛋白表达下降,且仅见于未用抗精神病药个体;小鼠过表达缺失外显子4的CPEB4可重现相关分子改变与精神分裂症样行为。
要点
- 精神分裂症相关基因在CPEB4结合转录本中富集。
- 精神分裂症患者CPEB4微外显子使用减少,仅未用药者与靶基因蛋白下降相关。
- 小鼠轻度过表达CPEB4Δ4可降低靶基因蛋白并出现精神分裂症样行为。
核心结论
- CPEB4异常剪接及下游精神分裂症风险基因错误表达是精神分裂症的新病因机制。
研究设计与样本
- 对精神病学基因组联盟全基因组关联研究数据进行MAGMA富集分析,并分析PsychENCODE联盟RNA测序数据。
- 对死後脑组织进行逆转录聚合酶链反应和蛋白质印迹,并通过毒理学分析评估抗精神病药存在与否。
- 构建轻度过表达缺失外显子4的CPEB4(CPEB4Δ4)小鼠,进行生化与行为学分析。
主要发现
- 精神分裂症相关基因在CPEB4结合转录本中富集。
- 精神分裂症先证者CPEB4微外显子使用减少,且仅无抗精神病药个体中与CPEB4靶向精神分裂症相关基因蛋白水平下降相关。
- 在CPEB4微外显子包含减少的精神分裂症先证者中,差异表达基因与已报道的精神分裂症基因相符。
- 轻度过表达CPEB4Δ4小鼠显示CPEB4靶向精神分裂症基因蛋白水平下降及精神分裂症相关行为。
临床怎么用
- 提示CPEB4剪接异常及下游靶基因表达下调可能作为精神分裂症病因相关生物标志物,但需进一步临床验证。
局限性
- 研究未明确报告样本量、效应值及置信区间等具体数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Schizophrenia (SCZ) is caused by an interplay of polygenic risk and environmental factors, which may alter regulators of gene expression leading to pathogenic misexpression of SCZ risk genes. The CPEB family of RNA-binding proteins (CPEB1-4) regulates translation of target RNAs (approximately 40% of overall genes). We previously identified CPEB4 as a key dysregulated translational regulator in autism spectrum disorder (ASD) because its neuronal-specific microexon (exon 4) is mis-spliced in ASD brains, causing underexpression of numerous ASD risk genes. The genetic factors and pathogenic mechanisms shared between SCZ and ASD led us to hypothesize CPEB4 mis-splicing in SCZ leading to underexpression of multiple SCZ-related genes. METHODS: We performed MAGMA-enrichment analysis on Psychiatric Genomics Consortium genome-wide association study data and analyzed RNA sequencing data from the PsychENCODE Consortium. Reverse transcriptase polymerase chain reaction and Western blot were performed on postmortem brain tissue, and the presence/absence of antipsychotics was assessed through toxicological analysis. Finally, mice with mild overexpression of exon 4-lacking CPEB4 (CPEB4Δ4) were generated and analyzed biochemically and behaviorally. RESULTS: First, we found enrichment of SCZ-associated genes for CPEB4-binder transcripts. We also found decreased usage of CPEB4 microexon in SCZ probands, which was correlated with decreased protein levels of CPEB4-target SCZ-associated genes only in antipsychotic-free individuals. Interestingly, differentially expressed genes fit those reported for SCZ, specifically in the SCZ probands with decreased CPEB4-microexon inclusion. Finally, we demonstrated that mice with mild overexpression of CPEB4Δ4 showed decreased protein levels of CPEB4-target SCZ genes and SCZ-linked behaviors. CONCLUSIONS: We identified aberrant CPEB4 splicing and downstream misexpression of SCZ risk genes as a novel etiological mechanism in SCZ.
引用
- Ollà I, Pardiñas AF, Parras A, et al. Pathogenic Mis-splicing of CPEB4 in Schizophrenia. Biol Psychiatry. 2023. PMID: 36958377. doi:10.1016/j.biopsych.2023.03.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。